Participation of Semaphorin Family and Plexins in the Clinical Course of Patients with Inflammatory Bowel Disease
- PMID: 39596507
- PMCID: PMC11595178
- DOI: 10.3390/ijms252212442
Participation of Semaphorin Family and Plexins in the Clinical Course of Patients with Inflammatory Bowel Disease
Abstract
Semaphorins are an immunoregulatory protein family. Plexins bind semaphorins (SEMAs) and can form receptor complexes that give them chemotactic capacity. The role and expression profile of semaphorins and plexins in inflammatory bowel disease (IBD) is currently unknown.
Aim: Characterize the semaphorins and plexins gene and protein expression in intestinal tissue from IBD patients and correlate them with the clinical phenotype.
Material and methods: This comparative and cross-sectional study enrolled 54 diagnosed IBD patients and 20 controls. Gene and protein expression of semaphorins and plexins were determined by RT-PCR and IHQ for the co-localization with neutrophils (myeloperoxidase, MPO) or CD123 plasmacytoid dendritic cells in intestinal tissue from IBD patients.
Results: Colonic mucosa from active and remission ulcerative colitis (UC) had a significantly lower SEMA4D and PLXNA1, but higher PLXNB1 gene expression than the control group. The only significant difference between active UC and remission was observed in the higher gene expression of SEMA6D in remission. It was associated with histological remission (p = 0.01, OR = 15, 95% CI: 1.39-16.1). The low expression of PLXNA1 was associated with mild intermittent activity with two relapses per year (p = 0.003, OR = 0.05, CI = 0.006-0.51). Higher SEMA4D+ positive cells were detected in the submucosa, while PLXNC1+/MPO+ in the mucosal and submucosa of active UC patients compared with controls.
Conclusions: The increased expression of the semaphorin and plexin family in IBD patients suggests their immunoregulatory function and is associated with remission and clinical phenotype in patients with UC.
Keywords: IBD; plexins; semaphorins.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Semaphorin-plexin signalling genes associated with human breast tumourigenesis.Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2. Gene. 2011. PMID: 21925246
-
Structural basis of semaphorin-plexin signalling.Nature. 2010 Oct 28;467(7319):1118-22. doi: 10.1038/nature09468. Epub 2010 Sep 26. Nature. 2010. PMID: 20877282 Free PMC article.
-
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.PLoS One. 2013 Jul 26;8(7):e69839. doi: 10.1371/journal.pone.0069839. Print 2013. PLoS One. 2013. PMID: 23922818 Free PMC article.
-
Roles of Sema4D and Plexin-B1 in tumor progression.Mol Cancer. 2010 Sep 21;9:251. doi: 10.1186/1476-4598-9-251. Mol Cancer. 2010. PMID: 20858260 Free PMC article. Review.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous